Print this page
-
A Phase II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers.
Protocol: 192204Principal Investigator:
- Christian Hinrichs (Rutgers University)
Applicable Disease Sites: Other Male Genital
Larynx
Other Female Genital
Cervix
Anus
Lip, Oral Cavity and Pharynx -
SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined with Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men with Newly Diagnosed Metastatic Prostate Cancer. (Multi-center)
Protocol: 081707Principal Investigator:
- Saum Ghodoussipour (Rutgers University)
Applicable Disease Sites: Prostate -
A Phase II Randomized Pilot Study Comparing High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy in Localized Prostate Cancer.
Protocol: 081805Principal Investigator:
- Lara Hathout MD (Rutgers University)
Applicable Disease Sites: Prostate -
A Feasibility Study of E7 TCR-T Cell Induction Therapy for Locoregionally Advanced HPV-Associated Cancers
Protocol: 192104Principal Investigator:
- Christian Hinrichs (Rutgers University)
Applicable Disease Sites: Breast
Stomach
Cervix
Other Male Genital
Lip, Oral Cavity and Pharynx
Other Female Genital -
Prostate Cancer Care Communication (PCCC): Impact of Support Person Presence on Communication During Medical Appointments.
Protocol: 132209Principal Investigator:
- Kathryn Greene PhD (Rutgers University)
Applicable Disease Sites: Prostate -
Choices About Genetic Testing And Learning Your Risk with Smart Technology (CATALYST)
Protocol: 132307Principal Investigator:
- Anita Kinney PhD,RN (Rutgers University)
Applicable Disease Sites: Pancreas
Other Female Genital
Prostate
Colon
Ovary
Breast